{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T09:09:14Z","timestamp":1779008954657,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Placenta"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.placenta.2026.02.012","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:18:58Z","timestamp":1771287538000},"page":"90-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Histopathological placental findings in antiphospholipid antibody carriers with a fetal loss beyond 12 weeks of pregnancy"],"prefix":"10.1016","volume":"176","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3557-9812","authenticated-orcid":false,"given":"Sara","family":"Be\u00e7a","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Borrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Santana-Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricard","family":"Cervera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesc","family":"Figueras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Peguero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfons","family":"Nadal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerard","family":"Espinosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7022-5270","authenticated-orcid":false,"given":"N\u00faria","family":"Ba\u00f1os","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.placenta.2026.02.012_bib1","unstructured":"Euro-Peristat Project. European Perinatal Health Report. Core Indicators of the Health and Care of Pregnant Women and Babies in Europe from 2015 to 2019.Accessed on 20 August 2025."},{"key":"10.1016\/j.placenta.2026.02.012_bib2","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ogc.2021.03.001","article-title":"Fetal growth and stillbirth","volume":"48","author":"Page","year":"2021","journal-title":"Obstet. Gynecol. Clin. North Am"},{"key":"10.1016\/j.placenta.2026.02.012_bib3","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.placenta.2014.05.011","article-title":"Systematic review of placental pathology reported in association with stillbirth","volume":"35","author":"Ptacek","year":"2014","journal-title":"Placenta"},{"key":"10.1016\/j.placenta.2026.02.012_bib4","doi-asserted-by":"crossref","first-page":"698","DOI":"10.5858\/arpa.2015-0225-CC","article-title":"Sampling and definitions of placental lesions: Amsterdam placental workshop group consensus statement","volume":"140","author":"Khong","year":"2016","journal-title":"Arch. Pathol. Lab Med."},{"key":"10.1016\/j.placenta.2026.02.012_bib5","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/s41379-021-00747-4","article-title":"Four major patterns of placental injury: a stepwise guide for understanding and implementing the 2016 Amsterdam consensus","volume":"34","author":"Redline","year":"2021","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.placenta.2026.02.012_bib6","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.ajog.2015.05.056","article-title":"Classification of placental lesions","volume":"213","author":"Redline","year":"2015","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.placenta.2026.02.012_bib7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.placenta.2024.09.015","article-title":"Placental lesions in stillbirth following the Amsterdam consensus: a systematic review and meta-analysis","volume":"158","author":"Narice","year":"2024","journal-title":"Placenta"},{"key":"10.1016\/j.placenta.2026.02.012_bib8","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1111\/jth.15053","article-title":"The prevalence of antiphospholipid antibodies in women with late pregnancy complications and low-risk for chromosomal abnormalities","volume":"18","author":"Foddai","year":"2020","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.placenta.2026.02.012_bib9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/humupd\/dmu049","article-title":"Antiphospholipid antibodies and the placenta: a systematic review of their in vitro effects and modulation by treatment","volume":"21","author":"Tong","year":"2015","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.placenta.2026.02.012_bib10","doi-asserted-by":"crossref","first-page":"6690","DOI":"10.1111\/jcmm.15321","article-title":"Antiphospholipid antibody-activated NETs exacerbate trophoblast and endothelial cell injury in obstetric antiphospholipid syndrome","volume":"24","author":"Lu","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.placenta.2026.02.012_bib11","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.autrev.2015.01.008","article-title":"Histopathology in the placentae of women with antiphospholipid antibodies: a systematic review of the literature","volume":"14","author":"Viall","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.placenta.2026.02.012_bib12","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1093\/rheumatology\/keaa499","article-title":"Maternal and foetal placental vascular malperfusion in pregnancies with anti-phospholipid antibodies","volume":"60","author":"Spinillo","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.placenta.2026.02.012_bib13","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.placenta.2023.06.013","article-title":"Correlation of placental lesions in patients with systemic lupus erythematosus, antiphospholipid syndrome and non-criteria obstetric antiphospholipid syndrome and adverse perinatal outcomes","volume":"139","author":"Castellanos Gutierrez","year":"2023","journal-title":"Placenta"},{"key":"10.1016\/j.placenta.2026.02.012_bib14","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1111\/jth.15047","article-title":"Guidance from the scientific and standardization committee for lupus anticoagulant\/antiphospholipid antibodies of the international society on thrombosis and haemostasis: update of the guidelines for lupus anticoagulant detection and interpretation","volume":"18","author":"Devreese","year":"2020","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.placenta.2026.02.012_bib15","unstructured":"A. Heerema-McKenney, E. J. Popek, M. E. De Paepe. Diagnostic pathology. Placenta. Second edition. ed. xvi, 413 pages, xvii p."},{"key":"10.1016\/j.placenta.2026.02.012_bib16","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00428-019-02639-0","article-title":"Fetal autopsy parameters standards: biometry, organ weights, and long bone lengths","volume":"475","author":"Bartosch","year":"2019","journal-title":"Virchows Arch."},{"key":"10.1016\/j.placenta.2026.02.012_bib17","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejogrb.2006.12.015","article-title":"Customized birthweight standards for a Spanish population","volume":"136","author":"Figueras","year":"2008","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.placenta.2026.02.012_bib18","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.placenta.2024.06.019","article-title":"Criteria and non-criteria antiphospholipid autoantibodies screening in patients with late pregnancy morbidity: a cross-sectional study","volume":"154","author":"Gros","year":"2024","journal-title":"Placenta"},{"key":"10.1016\/j.placenta.2026.02.012_bib19","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/rheumatology\/keaa203","article-title":"EUREKA algorithm predicts obstetric risk and response to treatment in women with different subsets of anti-phospholipid antibodies","volume":"60","author":"Pregnolato","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.placenta.2026.02.012_bib20","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/jth.15585","article-title":"Semiquantitative interpretation of anticardiolipin and antibeta2glycoprotein I antibodies measured with various analytical platforms: communication from the ISTH SSC subcommittee on Lupus anticoagulant\/antiphospholipid antibodies","volume":"20","author":"Vandevelde","year":"2022","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.placenta.2026.02.012_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.967178","article-title":"Comparison of non-criteria antiphospholipid syndrome with definite antiphospholipid syndrome: a systematic review","volume":"13","author":"Pires da Rosa","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.placenta.2026.02.012_bib22","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13075-020-2131-4","article-title":"\"Non-criteria\" antiphospholipid antibodies add value to antiphospholipid syndrome diagnoses in a large Chinese cohort","volume":"22","author":"Liu","year":"2020","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.placenta.2026.02.012_bib23","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/rheumatology\/keab414","article-title":"'Non-criteria antiphospholipid antibodies': bridging the gap between seropositive and seronegative antiphospholipid syndrome","volume":"61","author":"Truglia","year":"2022","journal-title":"Rheumatology"},{"key":"10.1016\/j.placenta.2026.02.012_bib24","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.semarthrit.2016.05.006","article-title":"Non-conventional antiphospholipid antibodies in patients with clinical obstetrical APS: prevalence and treatment efficacy in pregnancies","volume":"46","author":"Mekinian","year":"2016","journal-title":"Semin. Arthritis Rheum."}],"container-title":["Placenta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400426000597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400426000597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T08:29:25Z","timestamp":1779006565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143400426000597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":24,"alternative-id":["S0143400426000597"],"URL":"https:\/\/doi.org\/10.1016\/j.placenta.2026.02.012","relation":{},"ISSN":["0143-4004"],"issn-type":[{"value":"0143-4004","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histopathological placental findings in antiphospholipid antibody carriers with a fetal loss beyond 12 weeks of pregnancy","name":"articletitle","label":"Article Title"},{"value":"Placenta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.placenta.2026.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}